Drug
Insulin Tregopil
Insulin Tregopil: highest development phase Phase 2/3, developed by Biocon. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2/3
- Developer
- Biocon
Trials
| Drug | Phase | Indication |
|---|---|---|
| Insulin Tregopil NCT03430856 | Phase 2/3 | Type2 Diabetes Mellitus |
Latest
No recent events.
Follow Insulin Tregopil on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.